16 transactions on file, per SEC Form 4 filings.
See DGX superinvestor activity →Davis J. E.
CEO and President · 2026-09-01
Sold
$2.4M
PREVOZNIK MICHAEL E
SVP & General Counsel · 2026-08-28
Option exercise
$2.5M
PREVOZNIK MICHAEL E
SVP & General Counsel · 2026-08-28
Sold
$3.9M
PREVOZNIK MICHAEL E
SVP & General Counsel · 2026-08-28
Sold
$1.5M
PREVOZNIK MICHAEL E
SVP & General Counsel · 2026-08-28
Sold
$105K
PREVOZNIK MICHAEL E
SVP & General Counsel · 2026-08-28
G-Gift
1,000 sh
DELANEY MARK E
SVP & Chief Commercial Officer · 2026-07-28
Sold
$376K
CARTER ROBERT B
director · 2026-07-22
L-Small
$2K
Gregg Vicky B
director · 2026-07-22
Award
$15K
KUPPUSAMY KARTHIK
SVP, Clinical Solutions · 2026-07-22
L-Small
$8K
Plewman Patrick
SVP for Diagnostic Services · 2026-07-22
L-Small
$10K
MAIN TIMOTHY L
director · 2026-07-22
L-Small
$4K
SAMAD SAM
Executive Vice President & CFO · 2026-07-22
Award
$21K
Lassiter Wright III
director · 2026-07-22
L-Small
$1K
DELANEY MARK E
SVP & Chief Commercial Officer · 2026-07-22
L-Small
$7K
WENTWORTH TIMOTHY C
director · 2026-07-01
Award
144 sh
Each row links to the underlying SEC filing. Sells are shown for transparency, not as a signal — see the insider trading article for why.
Following an insider into a stock isn't a strategy on its own. Run your own margin-of-safety analysis, free.
Analyze DGX